COLL
Collegium Pharmaceutical, Inc.
NASDAQ · USHealthcareDrug Manufacturers - Specialty & Generic
$35.54-1.50%
Price as of Jul 20, 2026
COLL capital
Collegium Pharmaceutical, Inc. capital & dividend
Leverage, liquidity, debt coverage and shareholder-distribution metrics.
Leverage
- Debt / equity
- 2.59x
- Net debt / equity
- 1.73x
- Debt / assets
- 0.49x
- Debt / EBITDA
- 1.32x
- Net debt / EBITDA
- 0.88x
Liquidity & coverage
- Current ratio
- 1.71x
- Quick ratio
- 1.62x
- Cash ratio
- 0.97x
- Interest coverage
- 1.17x
- EBITDA / interest
- 3.74x
- Working capital
- $310.7M
Cash & dividend
- FCF / debt
- 0.41x
- Cash flow / debt
- 0.41x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.